Multiplexed immunohistochemistry and digital pathology as the foundation for next-generation pathology in melanoma research KU Leuven
Immunomodulatory therapies are revolutionizing the world of melanoma therapeutics. But immunomodulatory therapies are effective only on subset of melanoma patients. Identification of predictive biomarkers can significantly improve the efficiency of immunomodulatory therapies. In this project we plan to use multiplex immunohistochemistry and digital pathology to 1. more accurately classify melanoma subtypes on the basis of the subtype nad ...